Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose

BACKGROUND: European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint criteria for methicillin-susceptible Staphylococcus aureus (MSSA) treatment with ceftriaxone are based upon high dose (4 g/day) rather than standard dose (2 g/day) posology. This is particularly relevant for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mistry, Rakhee, Rawson, Timothy M., Troise, Oliver, Mughal, Nabeela, Moore, Luke S. P., Hughes, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789631/
https://www.ncbi.nlm.nih.gov/pubmed/36566229
http://dx.doi.org/10.1186/s12879-022-07925-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789631/
https://www.ncbi.nlm.nih.gov/pubmed/36566229
http://dx.doi.org/10.1186/s12879-022-07925-y

Ejemplares similares